Regular vs. selective use of closed suction drains following robot-assisted radical prostatectomy: results from a regional quality improvement collaborative
Autor: | Samer Kirmiz, Stephen K. Babitz, Brian R. Lane, James E. Montie, Ji Qi, Susan Linsell, Michigan Urological Surgery Improvement Collaborative, David C Miller, Christopher M. Brede |
---|---|
Rok vydání: | 2019 |
Předmět: |
Suction (medicine)
Cancer Research medicine.medical_specialty Ileus business.industry Prostatectomy Urology medicine.medical_treatment 030232 urology & nephrology Odds ratio Anastomosis medicine.disease Surgery 03 medical and health sciences 0302 clinical medicine Oncology 030220 oncology & carcinogenesis Suction drain medicine Outcomes research Adverse effect business |
Zdroj: | Prostate Cancer and Prostatic Diseases. 23:151-159 |
ISSN: | 1476-5608 1365-7852 |
DOI: | 10.1038/s41391-019-0170-1 |
Popis: | Closed suction drain (CSD) placement is common in robot-assisted radical prostatectomy (RARP). Our goal is to quantify outcomes of RARP for patients undergoing RARP by surgeons who regularly or selectively use CSDs. Patients undergoing RARP (4/2014−7/2017) were prospectively entered into the Michigan Urological Surgery Improvement Collaborative (MUSIC) registry. Outcomes included length of stay (LOS) >2 days, >16-day catheterization, 30-day readmission, and clinically significant urine leak or ileus. Retrospective analysis of each adverse event was performed comparing groups using chi-square tests. In all, 6746 RARPs were performed by 115 MUSIC surgeons. CSDs were used in 4451 RARP (66.0%), with wide variation in surgeon CSD use (median: 94.7%, range: 0–100%, IQR: 45–100%). The cohorts of patients treated by surgeons with regular vs. selective CSD usage were similar. CSD use pattern was not associated with rates of prolonged catheterization (4.6% vs. 3.9%, p = 0.17) or readmission (4.5% vs. 4.0%, p = 0.35) and multivariable analysis confirmed these findings (each p > 0.10). Regular CSD use was associated with LOS >2 days (8.4% vs. 6.3%, p = 0.001) and multivariable analyses indicated an odds ratio (OR) of 1.42 (95% CI: 1.12–1.79; p = 0.017) and increased likelihood of clinically significant ileus (OR: 1.64; CI: 1.14–2.35; p = 0.008). Although there are specific situations in which CSDs are beneficial, e.g. anastomotic leak or observed lymphatic drainage, regular CSD use during RARP was associated with a greater likelihood of LOS >2 days and clinically significant ileus. Our data suggest that CSD should be placed selectively rather than routinely after RARP. |
Databáze: | OpenAIRE |
Externí odkaz: |